Recording of the Cancer IO Sebinar Session IV: ‘Adoptive Cell Therapies’ on 2nd of December 2021is now online!
This time we heard about the latest developments in Adoptive Cell Therapies. We had the honor of hosting Boris Engels; Associate Director of the Novartis Institutes for Biomedical Research (Cambridge, USA), Dr. Sirpa Leppä (Physician in charge of the ward, Clinical Trial Unit of the Helsinki University Hospital and Professor at the University of Helsinki) and Dr. Anil Thorakura, Head of Immuno-Oncology at Orion Oy.
The recording is available below and on Youtube.
Program:
0:01:44 Introduction, Dr. Anil Thotakura, Orion Pharmaceuticals
0:12:22 Clinical trials with CAR-T therapies, Prof. Sirpa Leppä, Helsinki University Hospital
0:29:43 Reimagining new ground in cancer treatment: Present and future of CAR-T. Dr. Boris Engels, Associate Director of the Novartis Institutes for Biomedical Research, Cambridge, USA
1:15:13 Panel discussion: Opportunities and hurdles with clinical implementation of adoptive cell therapy (SPEAKERS + Matti Korhonen, Finnish Red Cross Blood Services).
Host: Cancer IO Director, FICAN Research Professor Juha Klefström.
